Jacksonville, FL - Data from a pharmacodynamic study suggests that acute coronary syndrome (ACS) patients can be safely switched from maintenance clopidogrel (Plavix, Bristol-Myers ...
Patients with chronic or acute coronary syndromes undergoing PCI have comparable safety and efficacy outcomes at 1 year no matter whether they were initially discharged on aspirin plus prasugrel or ...
Using prasugrel at the same time as cangrelor (Kengreal; Chiesi) during PCI creates an interaction that dampens antiplatelet effects and potentially leaves patients at risk for thrombotic ...
Expert Rev Clin Pharmacol. 2012;5(3):319-336. Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its ...
NEW YORK, Oct 23 (Reuters) - A small study presented on Monday suggests Eli Lilly and Co.'s experimental blood clot preventer, prasugrel, works faster and could be more effective than the commonly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback